Literature DB >> 14162957

LOW MOLECULAR WEIGHT DEXTRAN THERAPY IN SURGICAL SHOCK. 1. CONTROL GROUP AND SHOCK PATIENTS RESUSCITATED PRIOR TO LOW MOLECULAR WEIGHT DEXTRAN THERAPY.

R J BAKER, W C SHOEMAKER, F SUZUKI, R J FREEARK, E L STROHL.   

Abstract

Entities:  

Keywords:  BLOOD TRANSFUSION; BLOOD VOLUME; CLINICAL RESEARCH; DEXTRAN; DRUG THERAPY; SHOCK, SURGICAL

Mesh:

Substances:

Year:  1964        PMID: 14162957     DOI: 10.1001/archsurg.1964.01320020137020

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


× No keyword cloud information.
  2 in total

1.  Pharmacologic adjuncts to the management of shock.

Authors:  V J Collins; A P Winnie
Journal:  J Natl Med Assoc       Date:  1967-05       Impact factor: 1.798

2.  Effects of low molecular weight dextran on peripheral blood flow with controlled cardiac output.

Authors:  J W Kilman; J A Waldhausen; H B Schumacker
Journal:  Ann Surg       Date:  1967-08       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.